Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
about
Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disordersThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmOlanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.Combination therapy for manic phases: a critical review of a common practice.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Antipsychotic switching in bipolar disorders: a systematic review.Pain-processing abnormalities in bipolar I disorder, bipolar II disorder, and schizophrenia: A novel trait marker for psychosis proneness and functional outcome?Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses.A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder.Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression.Clinically relevant interactions between newer antidepressants and second-generation antipsychotics.Lithium for bipolar disorder: a review of the recent literature.Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy.Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Drugs under early investigation for the treatment of bipolar disorder.Power-up: A Reanalysis of 'Power Failure' in Neuroscience Using Mixture Modeling.Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder.Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd).Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study.Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy.Model Development of Mothering by Women with Bipolar Illness.
P2860
Q21129108-6122EE66-07EA-4716-8C05-9C7050834830Q28066714-A044DF92-A87C-4E03-8F71-BB26784E89A1Q33673618-9F81581D-36F9-4DD4-AEA5-52FF0D67EE2CQ34100578-CFF8ACB5-3B46-49E0-A98F-051D1CB0816BQ34272859-0D46AF27-6DFE-49F0-8A8A-F96B27A439F2Q34308027-892F03B5-94BA-4C96-8275-FA2C88864AFBQ34649187-3BC932DC-35BB-4C42-952B-BC0860100015Q35020871-9C241C72-F99B-44CC-B076-3DDB088CE4E9Q36174465-72125BCB-A14B-4847-91AD-10DA7C551455Q37279424-E03684DF-C573-4946-B4D7-D9F453288A18Q37632466-E3216315-AB8A-46F9-9F73-AA1B5CBEAC41Q38072081-302425F9-9951-4D6F-98F4-1C649B2E4946Q38185057-34B8843F-9DE8-42A4-BD51-B9AFB7C6B9B3Q38240532-07920078-CF32-43AB-A488-03D262DD57B2Q38244115-44FFAD13-2DB5-4202-8B9B-34EC5D958277Q38246706-56C7B837-EE80-487E-B5E0-DAE74DB70F1DQ38284625-6DC3EBF7-AD05-4A79-96DD-C0711A227E35Q38364032-DAEA5877-54B1-4074-94F4-D324CFDF03ECQ38680064-026766B9-79C8-4F9A-93F6-6D8207CC7448Q38969300-07A010D2-F125-4D55-BFC6-700FAC16D0A6Q39287194-BC6EDD63-35EC-40C6-BF52-A032B5515834Q42603284-5932AF13-DEC3-4488-A9F7-D9424EECEBA7Q43618621-8C1BA4FE-BDF0-45EE-8BE5-21E639FD794AQ44142664-A2C4A6D4-300F-4B11-BA1C-64B377523F75Q44403456-C520BFAA-54FC-4965-AFF0-BAFC94F17322Q48448795-2F6AC9F5-C5DF-44FB-8C21-4E2EFB725ACEQ48686688-86284F10-784A-4796-A115-659D8143840CQ50233085-F63FF852-D6AA-401D-94C5-8B662A53B175
P2860
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effectiveness of psychotropic ...... randomized controlled trials.
@ast
Effectiveness of psychotropic ...... randomized controlled trials.
@en
Effectiveness of psychotropic ...... randomized controlled trials.
@nl
type
label
Effectiveness of psychotropic ...... randomized controlled trials.
@ast
Effectiveness of psychotropic ...... randomized controlled trials.
@en
Effectiveness of psychotropic ...... randomized controlled trials.
@nl
prefLabel
Effectiveness of psychotropic ...... randomized controlled trials.
@ast
Effectiveness of psychotropic ...... randomized controlled trials.
@en
Effectiveness of psychotropic ...... randomized controlled trials.
@nl
P2093
P2860
P1476
Effectiveness of psychotropic ...... randomized controlled trials.
@en
P2093
Björn Paulsson
Carolin Miltenburger
Julie Locklear
Mary Lou Chatterton
Mattias Ekman
Mikael Åström
Oliver Günther
P2860
P304
P356
10.1017/S1461145711000885
P50
P577
2011-06-22T00:00:00Z